功能基因体学市场－全球产业规模、份额、趋势、机会和预测，依产品、技术、应用、最终用户、地区和竞争格局划分，2020-2030年预测

2024年全球功能基因体学市场规模为104.3亿美元，预计2030年将以9.30%的复合年增长率成长至177.8亿美元。功能基因组学是对生物体内基因和蛋白质功能及其相互作用进行系统研究，以阐明生物过程和表型表达。该市场的成长主要得益于高通量测序技术的进步、基因组研究投资的增加以及全球对个人化医疗和标靶治疗日益增长的需求。此外，慢性病和遗传性疾病的日益普遍也极大地推动了对先进基因组学知识和诊断工具的需求。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球功能基因体学市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品分类（试剂盒及检测方法、仪器）
  • 依技术分类（次世代定序 (NGS)、聚合酶炼式反应 (PCR)、微阵列、其他技术）
  • 依应用领域（表观基因体学、转录体学、蛋白质体学、代谢体学）
  • 按最终用户分类（学术和研究机构、生物技术和生物製药公司、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美功能基因体学市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲功能基因体学市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太功能基因体学市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲功能基因体学市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲功能基因体学市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球功能基因体学市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Danaher Corporation (Integrated DNA Technologies, Inc.)
• F. Hoffmann-La Roche Ltd.
• Illumina, Inc.
• MRM Proteomics Inc
• Perkin Elmer, Inc.
• QIAGEN NV
• ¬¬¬Thermo Fisher Scientific, Inc.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Functional Genomics Market, valued at USD 10.43 Billion in 2024, is projected to experience a CAGR of 9.30% to reach USD 17.78 Billion by 2030. Functional genomics involves the systematic investigation of gene and protein functions and their interactions within an organism to elucidate biological processes and phenotypic expression. The market's expansion is fundamentally driven by advancements in high-throughput sequencing technologies, increasing investments in genomic research, and the escalating global demand for personalized medicine and targeted therapies. Furthermore, the growing prevalence of chronic diseases and genetic disorders contributes significantly to the imperative for advanced genomic understanding and diagnostic tools.

Key Market Drivers

The Global Functional Genomics Market is significantly influenced by ongoing technological advancements in genomic sequencing, which continuously enhance the efficiency and accessibility of genetic analysis. Breakthroughs in sequencing platforms have dramatically reduced the cost and increased the speed of generating genomic data, enabling researchers to conduct studies at an unprecedented scale. For instance, according to *Next-Generation Sequencing Costs: The Sub $100 Genome*, in September 2024, Complete Genomics released the DNBSEQ-T20x2 sequencing platform, capable of producing 50,000 whole genome sequences per year for less than $100 per 30x human genome. This reduction makes population-scale functional genomics projects more feasible, fostering a deeper understanding of gene function in health and disease and driving the discovery of new therapeutic targets and biomarkers. The increased throughput allows for more extensive experimental designs, moving beyond single-gene studies to comprehensive functional analyses across entire genomes or transcriptomes.

Key Market Challenges

A significant challenge impeding the growth of the Global Functional Genomics Market is the substantial initial investment and ongoing operational costs associated with its specialized technologies and required expertise. These financial demands directly limit market adoption, particularly among smaller research institutions and emerging biotechnology firms. Such entities frequently lack the extensive capital resources necessary to acquire high-throughput sequencing platforms, establish robust bioinformatics infrastructure, and recruit skilled personnel essential for functional genomics research. This financial barrier restricts overall market expansion by reducing the number of active participants and the volume of genomic studies undertaken globally.

Key Market Trends

The integration of Artificial Intelligence and Machine Learning for genomic analysis represents a significant trend in the Global Functional Genomics Market, transforming how complex biological data is interpreted and utilized. These technologies enhance the precision and speed of identifying gene functions, understanding disease mechanisms, and discovering therapeutic targets by processing vast datasets that would be unmanageable through traditional methods. According to a Pistoia Alliance survey conducted in October 2025, 77% of life sciences laboratories anticipate using AI within the next two years, with AI remaining the top investment area for 63% of respondents for the third consecutive year. This demonstrates a strong industry commitment to leveraging AI for advanced genomic insights.

Key Market Players

• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Danaher Corporation (Integrated DNA Technologies, Inc.)
• F. Hoffmann-La Roche Ltd.
• Illumina, Inc.
• MRM Proteomics Inc
• Perkin Elmer, Inc.
• QIAGEN N.V.
• ¬¬¬Thermo Fisher Scientific, Inc.

Report Scope:

In this report, the Global Functional Genomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Functional Genomics Market, By Product:

• Kits & Assays
• Instruments

Functional Genomics Market, By Technology:

• Next-Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• Microarray
• Other Technologies

Functional Genomics Market, By Application:

• Epigenomics
• Transcriptomics
• Proteomics
• Metabolomics

Functional Genomics Market, By End-User:

• Academic and Research Institutions
• Biotechnology and Biopharmaceutical Companies
• Others

Functional Genomics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Functional Genomics Market.

Available Customizations:

Global Functional Genomics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Functional Genomics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Kits & Assays, Instruments)
  • 5.2.2. By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, Other Technologies)
  • 5.2.3. By Application (Epigenomics, Transcriptomics, Proteomics, Metabolomics)
  • 5.2.4. By End-User (Academic and Research Institutions, Biotechnology and Biopharmaceutical Companies, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Functional Genomics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technology
  • 6.2.3. By Application
  • 6.2.4. By End-User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Functional Genomics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End-User
  • 6.3.2. Canada Functional Genomics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End-User
  • 6.3.3. Mexico Functional Genomics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End-User

7. Europe Functional Genomics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technology
  • 7.2.3. By Application
  • 7.2.4. By End-User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Functional Genomics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End-User
  • 7.3.2. France Functional Genomics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End-User
  • 7.3.3. United Kingdom Functional Genomics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End-User
  • 7.3.4. Italy Functional Genomics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End-User
  • 7.3.5. Spain Functional Genomics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End-User

8. Asia Pacific Functional Genomics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technology
  • 8.2.3. By Application
  • 8.2.4. By End-User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Functional Genomics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End-User
  • 8.3.2. India Functional Genomics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End-User
  • 8.3.3. Japan Functional Genomics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End-User
  • 8.3.4. South Korea Functional Genomics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End-User
  • 8.3.5. Australia Functional Genomics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End-User

9. Middle East & Africa Functional Genomics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technology
  • 9.2.3. By Application
  • 9.2.4. By End-User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Functional Genomics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End-User
  • 9.3.2. UAE Functional Genomics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End-User
  • 9.3.3. South Africa Functional Genomics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End-User

10. South America Functional Genomics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technology
  • 10.2.3. By Application
  • 10.2.4. By End-User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Functional Genomics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End-User
  • 10.3.2. Colombia Functional Genomics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End-User
  • 10.3.3. Argentina Functional Genomics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Functional Genomics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Agilent Technologies, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Becton, Dickinson and Company
• 15.3. Bio-Rad Laboratories, Inc.
• 15.4. Danaher Corporation (Integrated DNA Technologies, Inc.)
• 15.5. F. Hoffmann-La Roche Ltd.
• 15.6. Illumina, Inc.
• 15.7. MRM Proteomics Inc
• 15.8. Perkin Elmer, Inc.
• 15.9. QIAGEN N.V.
• 15.10. ¬¬¬Thermo Fisher Scientific, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer